To receive our monthly eNews as well as event notices and other updates, just enter your email address.
The NYAM Section on Dermatology was pleased to present its annual Dermatology Residents’ Night on June 10, 2014. Over 130 dermatologists including program directors, faculty, and colleagues, and dermatology residents representing residency programs across New York and New Jersey gathered at NYAM for an evening of original research presentations, dinner, and networking.
“The research presented was of the highest caliber—investigative dermatology is thriving and will continue to do so in the hands of the next generation of dermatologists, such as those who presented at this NYAM program,” said Dermatology Section Chair Adam Friedman, MD, of the Division of Dermatology at Montefiore-Einstein College of Medicine.
The annual Residents’ Night engages area residency programs in selecting top residents to participate. Each year, NYAM invites the program director of each residency program to select one resident to present original research at the event. This year, nine residents from nine different programs presented research on subjects ranging from new biomarkers and targets for melanoma to mechanisms to increase patient compliance.
A panel of judges reviewed each participant on presentation, originality, and clinical significance of their research, and chose three winners. First prize ($500) went to David Miller, MD of Columbia Medical Center, for his research on “CDK7 Inhibition in Melanoma.” Two residents tied for second place ($175 each): Hadar Lev-Tov, MD of Albert Einstein College of Medicine and Allen Strickler, MD of Mount Sinai at St. Luke’s Roosevelt Hospital Center. Each presenter also received a certificate and a one-year complimentary Associate Membership to NYAM.
The NYAM Section on Dermatology gratefully acknowledges the support of the following organizations in presenting the 2014 Dermatology Residents’ Night: Acupath Laboratories, Inc, Amgen, Bayer HealthCare, Celgene, Galderma, Genentech, Janssen Biotech, Inc, La Roche-Posay, LEO Pharma, and Next Steps, sponsored by the AVEENO Brand.
Posted on June 12, 2014
Director of Marketing & Communications
The New York Academy of Medicine
1216 Fifth Avenue
New York, NY 10029
Reporters: to arrange interviews with NYAM medical and urban health experts, contact
Gina Ravosa, Director of Marketing & Communications
(212) 822-7285 / firstname.lastname@example.org
Drawing on the lessons of Superstorm Sandy, a new report from The New York Academy of Medicine (NYAM), “Resilient Communities: Empowering Older Adults in Disasters and Daily Life,” presents an innovative set of recommendations to strengthen and connect formal and informal support systems to keep older adults safe during future disasters.
A new issue brief from NYAM, “Achieving the Triple Aim in New York State: the Potential Role of Hospital Community Benefit,” is the first in a series related to promoting a better understanding of Community Benefit in New York State and how it can advance population health.
NYAM commissioned an analysis of hospital community benefit investments by New York State hospitals. The new issue brief analyzes the reported expenditures of NYS hospitals in the categories of the IRS Schedule H report.
Read press release